Talphera (TLPH) Shares Issued (2010 - 2026)
Talphera's (TLPH) quarterly Shares Issued came in at $4.0 million in Q1 2026, up 125.08% year-on-year from $1.8 million in Q1 2025, and up 53.38% quarter-over-quarter from $2.6 million in Q4 2025.
Talphera (TLPH) Shares Issued (2010 - 2026) Analysis & Trends
Talphera's Shares Issued history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- On a quarterly basis, Shares Issued rose 125.08% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 125.08% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 46.09% from the prior year.
- Shares Issued grew to $4.0 million in Q1 2026 per TLPH's latest filing, from $2.6 million in the prior quarter.
- Across five years, Shares Issued topped out at $15.6 million in Q1 2022 and bottomed at $725623.0 in Q4 2022.
- The 5-year median for Shares Issued is $1.8 million (2024), against an average of $3.3 million.
- Across the five-year window, Shares Issued slumped 94.26% in 2023 and soared 125.08% in 2026, its largest moves.
- Year by year, Shares Issued stood at $725623.0 in 2022, then gained by 23.11% to $893321.0 in 2023, then surged by 100.03% to $1.8 million in 2024, then surged by 46.09% to $2.6 million in 2025, then soared by 53.38% to $4.0 million in 2026.
- Per Business Quant, the three latest TLPH Shares Issued figures stand at $4.0 million (Q1 2026), $2.6 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 893,321.00 |
| Dec 31, 2023 | 893,321.00 |